The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Lacosamide Injection is used to treat partial-onset seizures.
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
This new fund is amongst the largest for the sector in India
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
Glenmark Pharmaceuticals won Innovation of the Year award
Subscribe To Our Newsletter & Stay Updated
